Stock Financial Ratios


RSLS / ReShape Lifesciences Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price1.59
Volume114,800.00
Market Cap ($M)15.15
Enterprise Value ($M)-8.33
Book Value ($M)2.94
Book Value / Share4.72
Price / Book0.30
NCAV ($M)2.98
NCAV / Share4.78
Price / NCAV0.69
Income Statement (mra) ($M)
Revenue0.79
EBITDA-22.80
Net Income-23.36
Balance Sheet (mrq) ($M)
Cash & Equivalents23.43
Cash / Share37.65
Assets55.18
Liabilities4.14
Quick Ratio0.97
Current Ratio1.41
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-7.95
Return on Assets (ROA)-3.32
Return on Equity (ROE)-7.95
Identifiers and Descriptors
CUSIP29365M208
Central Index Key (CIK)1371217
Industry Groups
SIC 3845 - Electromedical and Electrotherapeutic Apparatus
Other Related CUSIPS
29365M307
29365M908
29365M505
29365M955
29365M125
761123108
29365M958
29365M905
Share Statistics
Common Shares Outstanding (M)21.72
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.31
Assets Current Per Share41.14
Long Term Debt Per Share0.00
Inventory Per Share2.55
Treasury Stock Per Share0.00
Assets Other Non Current Per Share1.84
Accounts Payable Per Share0.00
Debt Per Share0.00
Accounts Receivable Per Share0.54
Cash Per Share37.65
Intangibles Per Share0.00
Goodwill Per Share10.28
Cash And Equivalents Per Share37.65
Liabilities Per Share6.64
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Assets Per Share88.66
Property Plant And Equipment Per Share0.31
Inventory Raw Materials Per Share0.00
Retained Earnings Per Share-522.37
Equity Per Share82.01
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Additional Paid In Capital Per Share604.18
Minority Interest Per Share0.00
Liabilities Current Per Share6.64
Liabilities And Stock Equity Per Share88.66

Related News Stories

ReShape Lifesciences' (RSLS) CEO Dan Gladney on Q3 2017 Results - Earnings Call Transcript

2017-11-15 seekingalpha
Good day, ladies and gentlemen. And welcome to the ReShape Lifesciences Third Quarter 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call may be recorded. (0-1)

CUSIP: 29365M208